Education
About Us
Working with TipRanks
Follow Us
CAFG - ETF AI Analysis
Top Page
Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Leading Holdings With Strong Gains
Several of the largest positions, such as Vicor and Powell Industries, have delivered strong year-to-date performance, helping drive the fund’s returns.
Focused Growth Sectors
Heavy exposure to technology and health care gives investors targeted access to sectors that have been key drivers of growth in the small-cap space.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Concentration in a Few Sectors
A large share of assets is concentrated in technology and health care, increasing the impact if these sectors experience a downturn.
Single-Country Exposure
With almost all holdings in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.
CAFG vs. SPDR S&P 500 ETF (SPY)
AUM20.10M
RegionNorth America
Expense Ratio0.59%
Beta0.90
IssuerPacer
Inception DateMay 02, 2023
Dividend Yield0.32%
Asset ClassEquity
Index TrackedPacer US Small Cap Cash Cows Growth Leaders Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,071
30 Day Avg. Volume5,607
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.37Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering99
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CAFG Summary
The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) tracks the Pacer US Small Cap Cash Cows Growth Leaders Index, focusing on smaller U.S. companies with strong cash flow and growth potential. It mainly holds technology and health care stocks, including names like DigitalOcean Holdings and Semtech. Someone might invest in this ETF to seek higher long-term growth and diversify beyond large, well-known companies by tapping into innovative small businesses. However, because it focuses on small, growth-oriented stocks, its price can be more volatile and may go up and down more sharply than the overall market.
How much will it cost me?The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on identifying small-cap companies with strong growth and cash flow potential.
What would affect this ETF?The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) could benefit from strong growth in sectors like technology and healthcare, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to thrive. However, small-cap stocks are often more sensitive to economic downturns and interest rate hikes, which could negatively impact the ETF's performance. Additionally, regulatory changes or sector-specific challenges in industries like energy or consumer cyclical could pose risks to its growth potential.
CAFG Top 10 Holdings
CAFG is leaning hard into U.S. small-cap growth, with a clear tilt toward tech and health care names that are either sprinting ahead or catching their breath. Vicor and Powell Industries are doing much of the heavy lifting, with rising share prices that set the tone for the fund. Krystal Biotech and Innovex are also adding fuel, reflecting strong momentum in innovative niches. On the flip side, Veracyte and PTC Therapeutics are lagging a bit, acting like mild headwinds rather than full-on drags in this otherwise growth-focused, domestically concentrated portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Vicor | 5.00% | $1.00M | $6.96B | 211.17% | 73 Outperform | |
| Powell Industries | 4.66% | $936.19K | $7.10B | 174.19% | 76 Outperform | |
| Semtech | 3.37% | $676.66K | $8.06B | 133.05% | 69 Neutral | |
| DigitalOcean Holdings | 2.52% | $505.71K | $6.24B | 53.13% | 73 Outperform | |
| Krystal Biotech | 2.48% | $498.09K | $8.02B | 80.40% | 80 Outperform | |
| Kulicke & Soffa | 2.23% | $447.54K | $3.75B | 74.38% | 61 Neutral | |
| PTC Therapeutics | 2.19% | $439.68K | $5.58B | 34.02% | 72 Outperform | |
| Innovex International | 2.11% | $424.23K | $1.71B | 50.52% | 76 Outperform | |
| InterDigital | 2.06% | $414.99K | $9.63B | 75.00% | 76 Outperform | |
| Pediatrix Medical Group | 2.04% | $410.19K | $1.85B | 53.17% | 76 Outperform |
CAFG Technical Analysis
Positive
―
Price Trends
26.63
Positive
26.07
Positive
25.35
Positive
Market Momentum
0.38
Negative
61.02
Neutral
72.97
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CAFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.49, equal to the 50-day MA of 26.63, and equal to the 200-day MA of 25.35, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 61.02 is Neutral, neither overbought nor oversold. The STOCH value of 72.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CAFG.
CAFG Peer Comparison
Comparison Results
Performance Comparison
CAFG
Pacer US Small Cap Cash Cows Growth Leaders ETF
28.00
1.83
6.99%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
QSML
WisdomTree U.S. SmallCap Quality Growth Fund
―
―
―
ACSG
American Century Small Cap Growth Insights ETF
―
―
―
SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents